Staten Biotechnology aims to develop novel and innovative strategies for the treatment of dyslipidemia.
Location: Netherlands, Gelderland, Nijmegen
Employees: 1-10
Investors 2
| Date | Name | Website |
| - | BioGenerat... | biogenerat... |
| - | Forbion | forbion.co... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 17.12.2018 | Novo bags €430M Staten buyout option to boost cardiovascular... | Novo Nordisk has landed an option to buy Staten Biotechnology in a €430 million ($485 million) deal.... | fiercebiot... |
| 17.12.2018 | Novo bags €430M Staten buyout option to boost cardiovascular... | Novo Nordisk has landed an option to buy Staten Biotechnology in a €430 million ($485 million) deal.... | fiercebiot... |
| 17.12.2018 | Novo Nordisk grabs a $486M buyout option on an anti-apoC... | A couple of months after restructuring its R&D operations, Novo Nordisk has whipped up ... | endpts.com... |